{
    "medicine_id": "7d1a136e1f394e8e0a8ab361c947b77f442f23b5",
    "platform_id": "DB05449",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v FM VP4",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in hyperlipidemia and cancer tumors unspecified Monotherapy is recommended for people with marginally high LDL cholesterol or who cannot be prescribed statins due to drug interactions and safety concerns Combination Therapy is recommended if statin therapy alone is either insufficient to achieve the guidelines set by the NCEP or there is concern over side effects as Statin doses can be lowered in combination treatment without losing efficacy",
            "contraindications": {
                "disease": "Clinical trials have indicated that the drug is well tolerated",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "FM VP4 is thought to bind competitively with cholesterol to MDR1 resulting in a synergistic decrease in cholesterol accumlation Others have suggested that FM VP4 may act by inhibiting a transporter that mediates intestinal absorption of cholesterol",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}